Ozanimod

SKU: orb1300342

Description

Ozanimod (RPC-1063) is an orally administered, selective sphingosine-1-phosphate receptor 1 (S1PR1) modulator. It is widely used in preclinical and clinical research for immune-mediated conditions, including investigations into multiple sclerosis and inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.

Research Area

Pharmacology & Drug Discovery

Key Properties

• CAS Number: 1306760-87-1
• MW: 404.46
• Purity: 98.68% (May vary between batches)
• Formula: C₂₃H₂₄N₄O₃
• SMILES: CC(C)Oc1ccc(cc1C#N)-c1nc(no1)-c1cccc2[C@H](CCc12)NCCO
• Target: S1P Receptor,LPL Receptor
• Solubility: Ethanol:10 mg/mL (24.72 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.94 mM);DMSO:41.67 mg/mL (103.03 mM);H2O:< 1 mg/mL (insoluble or slightly soluble)

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

neurosurgery, Ozanimod, Lysophospholipid Receptor, LPL Receptor, LPLReceptor, LPL, inhibit, multiple sclerosis (MS), Inhibitor, RPC1063, RPC-1063, RPC 1063, S1P1, S1PReceptor, S1P5, S1P receptor subtypes 1 (S1P1), S1P receptor subtypes 5 (S1P5), S1P Receptor, sphingosine 1-phosphate (S1P)

Quick Database Links

Gene Symbol

S1P Receptor,LPL Receptor